Kathleen A. Rickard is Chief Medical Officer at Verona Pharma plc (VRNA). They have made 2 open-market trades across 1 company since 2022, most recently 2025-10-07.
CIK 0001836883
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRNA | 1,131,984 | $121.0M |
Shares reported on the most recent Form 4, priced at the 2025-10-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRNA | SELL · 10b5-1 | 2025-08-01 | 2025-08-05 | $13.14 | $1.5M | +0.0% | +0.9% | N/A |
| VRNA | SELL · 10b5-1 | 2025-05-06 | 2025-05-08 | $8.82 | $2.0M | +12.4% | +27.3% | +58.5% |
| VRNA | SELL · 10b5-1 | 2025-05-01 | 2025-05-05 | $8.95 | $881K | -2.0% | +18.4% | +48.7% |
| VRNA | SELL · 10b5-1 | 2025-04-29 | 2025-05-01 | $8.98 | $618K | -7.1% | +15.6% | +44.5% |
| VRNA | SELL · 10b5-1 | 2025-03-12 | 2025-03-13 | $8.35 | $1.3M | +5.5% | -7.9% | +43.5% |
| VRNA | SELL · 10b5-1 | 2024-11-25 | 2024-11-26 | $4.90 | $1.2M | +0.5% | +16.8% | +64.0% |
| VRNA | SELL · 10b5-1 | 2024-05-03 | 2024-05-03 | $1.96 | $142K | -11.1% | -23.8% | +44.1% |
| VRNA | SELL · 10b5-1 | 2024-02-05 | 2024-02-05 | $2.22 | $161K | -4.0% | -3.6% | -14.3% |
| VRNA | SELL · 10b5-1 | 2023-11-03 | 2023-11-03 | $1.92 | $226K | -6.7% | -11.1% | +20.4% |
| VRNA | SELL · 10b5-1 | 2023-08-03 | 2023-08-07 | $2.53 | $331K | -7.2% | +1.1% | -20.7% |
| VRNA | SELL · 10b5-1 | 2023-08-01 | 2023-08-03 | $2.66 | $141K | -10.0% | -3.4% | -29.3% |
| VRNA | SELL · 10b5-1 | 2023-05-01 | 2023-05-03 | $2.60 | $552K | -0.5% | +2.1% | +2.0% |
| VRNA | SELL | 2023-02-01 | 2023-02-03 | $2.55 | $606K | +2.4% | +5.5% | -1.9% |
| VRNA | SELL · 10b5-1 | 2022-11-01 | 2022-11-03 | $1.64 | $47K | -3.6% | +5.8% | +62.1% |
| VRNA | SELL · 10b5-1 | 2022-08-02 | 2022-08-03 | $0.70 | $20K | +113.0% | +75.8% | +125.1% |
| VRNA | SELL · 10b5-1 | 2022-05-03 | 2022-05-05 | $0.49 | $14K | +1.7% | +25.9% | +46.5% |
| VRNA | SELL | 2022-04-08 | 2022-04-12 | $0.57 | $99K | +2.3% | -17.2% | +0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.